Literature DB >> 1665462

An overview of the inactivation of FMDV and the implications when residual virus is present in vaccines.

F Brown1.   

Abstract

Most foot-and-mouth disease (FMD) vaccines are prepared by inactivating the virus with acetylethyleneimine or binary ethyleneimine. However, formaldehyde is still used by some manufacturers despite the well-documented evidence that inactivation with this reagent is not a linear or first-order reaction. Recent German work provides clear evidence that almost all the outbreaks in Western Europe in recent years have been caused by viruses closely related to strains which were isolated more than 20 years ago and are used for the production of vaccines. Moreover, with one exception, all the vaccines connected with the outbreaks were prepared by formaldehyde inactivation. The implications of these outbreaks are both immediate and longer term. The immediate effect is that they severely disrupt trading in meat and dairy products. The longer term effect has been the decision to abandon vaccination in Western Europe. This could have serious implications as trading with Eastern European countries will be expected to increase in the immediate future.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1665462

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  3 in total

Review 1.  The history of foot-and-mouth disease virus serotype C: the first known extinct serotype?

Authors:  David J Paton; Antonello Di Nardo; Nick J Knowles; Jemma Wadsworth; Edviges M Pituco; Ottorino Cosivi; Alejandro M Rivera; Labib Bakkali Kassimi; Emiliana Brocchi; Kris de Clercq; Consuelo Carrillo; Francois F Maree; Raj K Singh; Wilna Vosloo; Min-Kyung Park; Keith J Sumption; Anna B Ludi; Donald P King
Journal:  Virus Evol       Date:  2021-03-19

2.  Immunogenicity of a psoralen-inactivated dengue virus type 1 vaccine candidate in mice.

Authors:  Ryan C Maves; Roger M Castillo Oré; Kevin R Porter; Tadeusz J Kochel
Journal:  Clin Vaccine Immunol       Date:  2009-12-09

3.  Eastern equine encephalomyelitis virus infection in a horse from California.

Authors:  Robert P Franklin; Hailu Kinde; Michele T Jay; Laura D Kramer; Emily-Gene N Green; Robert E Chiles; Eileen Ostlund; Stan Husted; Jonathan Smith; Michael D Parker
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.